People on GLP-1 drugs appear to do less physical activity: study

Individuals taking GLP-1 drugs, commonly prescribed for weight loss and diabetes management, appear to significantly reduce their physical activity, a new study suggests. Participants using these medications showed a notable drop in daily steps and overall exercise.

The research observed that individuals on GLP-1 medications decreased their daily steps from an average of 5,047 to 4,487. Furthermore, their engagement in moderate-to-vigorous physical activity fell from 28 minutes per day to 22 minutes per day. This reduction in movement was observed even before any weight loss occurred, indicating a potential direct effect of the drugs on activity levels.

Researchers expressed concern that this decline in physical activity could potentially offset some of the health benefits associated with these popular drugs. While GLP-1 agonists have shown promise in aiding weight loss and improving glycemic control, the decrease in exercise might hinder long-term health outcomes. Further investigation is needed to understand the full implications and to develop strategies to encourage continued physical activity among patients using these medications.